0001387131-15-002579.txt : 20150817 0001387131-15-002579.hdr.sgml : 20150817 20150817172954 ACCESSION NUMBER: 0001387131-15-002579 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150813 FILED AS OF DATE: 20150817 DATE AS OF CHANGE: 20150817 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 310 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 310 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROTHERMEL ROBERT B CENTRAL INDEX KEY: 0001277431 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36242 FILM NUMBER: 151059686 MAIL ADDRESS: STREET 1: 828 BALMORAL LN CITY: NORTHBROOK STATE: IL ZIP: 60062 4 1 rothermel-form4_081315.xml OWNERSHIP DOCUMENT X0306 4 2015-08-13 0 0000887247 Adamis Pharmaceuticals Corp ADMP 0001277431 ROTHERMEL ROBERT B C/O ADAMIS PHARMACEUTICALS CORPORATION 11682 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2015-08-13 2015-08-13 4 P 0 5000 3.2988 A 25000 D Common Stock 2015-08-14 2015-08-14 4 P 0 2000 3.3998 A 27000 D The price reported in Column 4 is a weighted avergae price. These shares were purchased in multiple transactions at prices ranging from $3.24 to $3.30, inclusive. The reporting person undertakes to provide to Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.358 to $3.426, inclusive. The reporting person undertakes to provide to Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4. /s/ Robert O. Hopkins, Power of Attorney For Robert B. Rothermel 2015-08-17